Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting chromosomally unstable tumors with a selective KIF18A inhibitor.
Phillips AF, Zhang R, Jaffe M, Schulz R, Carty MC, Verma A, Feinberg TY, Arensman MD, Chiu A, Letso R, Bosco N, Queen KA, Racela AR, Stumpff J, Andreu-Agullo C, Bettigole SE, Depetris RS, Drutman S, Su SM, Cogan DA, Eng CH. Phillips AF, et al. Among authors: chiu a. Nat Commun. 2025 Jan 2;16(1):307. doi: 10.1038/s41467-024-55300-z. Nat Commun. 2025. PMID: 39747049 Free PMC article.
Risk factors for mortality after 3-column osteotomy.
Carbone J, Ratanpal A, Chiu AK, Suresh RI, Anderson B, Amatya B, Sahai A, Shear B, Ruditsky A, Ghenbot S, Bivona LJ, Jauregui JJ, Cavanaugh DL, Koh EY, Ludwig SC. Carbone J, et al. Among authors: chiu ak. Eur Spine J. 2024 Dec 23. doi: 10.1007/s00586-024-08616-9. Online ahead of print. Eur Spine J. 2024. PMID: 39714467
When free air is not under the diaphragm.
Chiu AK, Zapp Z. Chiu AK, et al. J Am Coll Emerg Physicians Open. 2024 Nov 27;5(6):e13275. doi: 10.1002/emp2.13275. eCollection 2024 Dec. J Am Coll Emerg Physicians Open. 2024. PMID: 39611028 Free PMC article. No abstract available.
Results of an Integrated Phase I/II Prospective Clinical Trial (NEXIS) for Neoadjuvant Anti-PD-L1 (Durvalumab) and Anti-CTLA-4 (Tremelimumab) With Radiation for High-Risk Soft-Tissue Sarcoma of the Trunk and Extremities.
Ng VY, Sahlani MN, Fogel JD, Chiu AK, Kallen ME, Davis D, Snider J, Regine W, Bentzen SM, Sausville E. Ng VY, et al. Among authors: chiu ak. Cureus. 2024 Oct 22;16(10):e72119. doi: 10.7759/cureus.72119. eCollection 2024 Oct. Cureus. 2024. PMID: 39575028 Free PMC article.
1,260 results